2023 Christmas Reading List
Marking the end of another busy year for the Cancer Prevention Group, we have hand picked 15 of our published research highlights for your festive […]
Breast screening
CanScreen5: A programme to improve the quality of cancer screening programmes
CanScreen5 Cancer Screening in Five Continents (CanScreen5) is a project analysing the organisation and implementation of breast, cervical and colorectal cancer screening programmes worldwide. It […]
Increasing screening uptake among Muslim women: Can their faith help?
This piece was co-written by guest authors Dr Marie Kotzur and Dr Floor Christie-de Jong. Dr Marie Kotzur is a Research Associate in the School […]
5 minutes with: Professor Stephen Duffy
Stephen Duffy is a statistician by training, educated at the University of Edinburgh and Imperial College, London. He has worked in the UK, Singapore, France, […]
How can we monitor improvements in early diagnosis?
This post was created by Amy Tickle, a Cancer Research UK-funded PhD student in the Cancer Prevention Group. Amy is currently in her second year […]
What are women’s views of personalised breast cancer risk assessment and risk-stratified breast screening?
This post was written by Charlotte Kelley Jones. Charlotte is a postgraduate research (PGR) student within the Faculty of Life Sciences & Medicine and School […]
Feel It On The First: An interview with breast cancer previvor and survivor Gila Pfeffer
Gila Pfeffer is a Jewish American writer and humourist currently living in the UK with her husband and four teenage children. Gila is a 13-year […]
What will women think about introducing risk-stratification to the NHS Breast Screening Programme? A behavioural science perspective.
This post was written by Charlotte Kelley Jones. Charlotte is a postgraduate research (PGR) student within the Faculty of Life Sciences & Medicine and School […]
The Ageing Soma, Screening and All-Cause Mortality
Paul Pharoah is Professor of Cancer Epidemiology at the University of Cambridge, where he leads research on the molecular pathology of breast and ovarian cancer […]
Breast screening for women in their 40s – what are we waiting for?
A friend of mine in her late 40s has just been diagnosed with breast cancer. Fortunately, she spotted it early and it sounds as if […]